These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 10560943)
1. Efficacy of a pure compound H1-A extracted from Cordyceps sinensis on autoimmune disease of MRL lpr/lpr mice. Yang LY; Chen A; Kuo YC; Lin CY J Lab Clin Med; 1999 Nov; 134(5):492-500. PubMed ID: 10560943 [TBL] [Abstract][Full Text] [Related]
2. [Effect of Cordyceps sinensis on inhibiting systemic lupus erythematosus in MRL 1pr/1pr mice (correction of rats)]. Fu T; Lin J Zhong Yao Cai; 2001 Sep; 24(9):658-9. PubMed ID: 11799778 [TBL] [Abstract][Full Text] [Related]
3. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of activated human mesangial cell proliferation by the natural product of Cordyceps sinensis (H1-A): an implication for treatment of IgA mesangial nephropathy. Lin CY; Ku FM; Kuo YC; Chen CF; Chen WP; Chen A; Shiao MS J Lab Clin Med; 1999 Jan; 133(1):55-63. PubMed ID: 10385482 [TBL] [Abstract][Full Text] [Related]
5. The effect of OM-89 (Subreum) on the murine model of systemic lupus erythematosus MRL-lpr/lpr. Dhaher YY; Khamashta MA; Hartley B; Taub N; Farine JC; Hughes GR Lupus; 1997; 6(5):436-40. PubMed ID: 9229361 [TBL] [Abstract][Full Text] [Related]
6. Immunomodulating effect of a traditional Japanese medicine, hachimi-jio-gan (ba-wei-di-huang-wan), on Th1 predominance in autoimmune MRL/MP-lpr/lpr mice. Furuya Y; Kawakita T; Nomoto K Int Immunopharmacol; 2001 Mar; 1(3):551-9. PubMed ID: 11367538 [TBL] [Abstract][Full Text] [Related]
7. Type I IFN protects against murine lupus. Hron JD; Peng SL J Immunol; 2004 Aug; 173(3):2134-42. PubMed ID: 15265950 [TBL] [Abstract][Full Text] [Related]
8. Jieduquyuziyin prescription suppresses IL-17 production and Th17 activity in MRL/lpr mice by inhibiting expression of Ca(2+)/calmodulin-dependent protein kinase-4. Shui B; Xia W; Wen C; Ding X J Nat Med; 2015 Jul; 69(3):349-57. PubMed ID: 25821132 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic targeting of BET protein BRD4 delays murine lupus. Wei S; Sun Y; Sha H Int Immunopharmacol; 2015 Dec; 29(2):314-319. PubMed ID: 26590112 [TBL] [Abstract][Full Text] [Related]
10. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011 [TBL] [Abstract][Full Text] [Related]
11. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice. Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682 [TBL] [Abstract][Full Text] [Related]
12. (5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/ Zhang LY; Li H; Wu YW; Cheng L; Yan YX; Yang XQ; Zhu FH; He SJ; Tang W; Zuo JP Am J Physiol Renal Physiol; 2017 Apr; 312(4):F769-F777. PubMed ID: 28100505 [TBL] [Abstract][Full Text] [Related]
13. Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL/lpr mice. Lui SL; Tsang R; Wong D; Chan KW; Chan TM; Fung PC; Lai KN Lupus; 2002; 11(7):411-8. PubMed ID: 12195781 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of (S)-armepavine from Nelumbo nucifera on autoimmune disease of MRL/MpJ-lpr/lpr mice. Liu CP; Tsai WJ; Shen CC; Lin YL; Liao JF; Chen CF; Kuo YC Eur J Pharmacol; 2006 Feb; 531(1-3):270-9. PubMed ID: 16413531 [TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of Bupleurum polysaccharides on autoimmune-prone MRL-lpr mice. Jiang YW; Li H; Zhang YY; Li W; Jiang YF; Ou YY; Chen DF Clin Dev Immunol; 2012; 2012():842928. PubMed ID: 22701502 [TBL] [Abstract][Full Text] [Related]
16. Demethylzeylasteral (T-96) Treatment Ameliorates Mice Lupus Nephritis Accompanied by Inhibiting Activation of NF-κB Pathway. Hu Q; Yang C; Wang Q; Zeng H; Qin W PLoS One; 2015; 10(7):e0133724. PubMed ID: 26208003 [TBL] [Abstract][Full Text] [Related]
17. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome. Su B; Ye H; You X; Ni H; Chen X; Li L Life Sci; 2018 Sep; 208():26-32. PubMed ID: 30146016 [TBL] [Abstract][Full Text] [Related]
18. The parasitic worm product ES-62 targets myeloid differentiation factor 88-dependent effector mechanisms to suppress antinuclear antibody production and proteinuria in MRL/lpr mice. Rodgers DT; McGrath MA; Pineda MA; Al-Riyami L; Rzepecka J; Lumb F; Harnett W; Harnett MM Arthritis Rheumatol; 2015 Apr; 67(4):1023-35. PubMed ID: 25546822 [TBL] [Abstract][Full Text] [Related]
19. Alleviation of renal disease and lymphadenopathy in MRL-Fasp(lrcg)/Fas(lprcg) (MR-lpr(cg)) mice neonatally infected with mouse mammary tumor virus encoding superantigen strongly reactive with TCR Vbeta8.2 element. Matsuzawa A; Yasuda T; Zhang Y; Nagase H; Yoshimoto T; Kimura M; Tsubura A Viral Immunol; 2000; 13(3):297-311. PubMed ID: 11016595 [TBL] [Abstract][Full Text] [Related]
20. Abrogation of skin disease in LUPUS-prone MRL/FASlpr mice by means of a novel tylophorine analog. Choi JY; Gao W; Odegard J; Shiah HS; Kashgarian M; McNiff JM; Baker DC; Cheng YC; Craft J Arthritis Rheum; 2006 Oct; 54(10):3277-83. PubMed ID: 17009262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]